Connect with us

Hi, what are you looking for?

Jewish Business News


Israeli Startup AiVF Raises $25 Million to Advance Fertility Tech

AiVF's leading team. L-R Professor Daniel Seidman, MD., Daniella Gilboa Prof. Dan Ariely/ Photo Eyal Toueg

AiVF, an Israeli startup that works at advancing technology for fertility treatments such as in vitro fertilization (the IVF in AiVF), raised $25 million in a Series A round led by Insight Partners, and including funding from WeWork founder Adam Neumann’s Family Office. The name AiVf is a combination of artificial intelligence (AI) and IVF. The company developed the first fully operational AI-based IVF software platform – EMA.

Founded in 2018, by CEO Daniella Gilboa together with Daniel Seidman, AiVF states that it was established to help people who dream of having a child, and the doctors and clinics that support this dream.

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.

“We are fundamentally transforming the IVF (in vitro fertilization) treatment journey with a unique combination of patent-pending advanced artificial intelligence technology, extensive clinical expertise, and vast sets of visual and other types of fertility data from around the globe,” says the company.

The company’s EMA platform provides an “optimized end-to-end IVF journey” to individuals seeking Assisted Reproductive Technologies for their family building.

EMA is a SAAS platform which uses AI technology to assist embryo evaluation and support operational efficiencies in IVF clinics. AiVF boasts that the advanced machine learning and computer vision algorithms the company developed have the potential to shorten the time to pregnancy and increase IVF predictability and success rates.

Daniella Gilboa is an embryologist — a type of biologist trained for IVF. Daniella once explained to TPS that the problem with IVF as it exists today is that “IVF is done very primitively today. It’s more of an art, based on gut feelings and so forth, so I wanted to bring in professional analytics instead of subjective human analysis.”

Daniella understands how important it is for people to start a family, and their disappointment at not being able to do so. She has three children herself. Daniella was living in Singapore when her first child was born. Becoming a mother filled her with a desire to help anyone who wants to have a baby be able to do so. This is why Daniella chose to go into embryology, because she thinks that it is, “the noblest profession in the world, I miss it terribly.”

“We can now leverage data to augment expertly trained clinicians, drive efficiencies and provide a new level of fertility care for all,” added Prof. Daniel Seidman, AiVF co-founder, chief medical officer, and an internationally renowned IVF specialist.



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.